Gregory Holcombe Purchases Shares of OBT

Gregory Holcombe made a purchase of 127 shares of OBT on June 15, 2026, at an average price of $35.35 per share. The transaction was valued at $4,489.45 and was not part of a pre-arranged trading plan.

Insider Buying and Selling at OBT

Several insiders at OBT have recently made share purchases. On June 15, 2026, Gregory Sousa, EVP and Deputy CLO, bought 25 shares at $35.35 each. William Morrison acquired 11 shares, Jonathan Rouis bought 37 shares, and Richard Rowley purchased 132 shares, all at the same price. Additionally, Kevin Keane acquired 92 shares, and Michael Lesler, EVP and Chief Financial Officer, bought 13 shares, each transaction occurring at $35.35 per share and not under a Rule 10b5-1 plan.

Other Institutional Activity in OBT

In recent institutional activity, BlackRock, Inc. reduced its holdings by 50,029 shares, leaving it with 1,892,320 shares valued at about $60.5 million. Orange Investment Advisors, Inc. also cut its stake by 40,127 shares, ending with 1,061,490 shares worth around $33.9 million. Wellington Management Group LLP trimmed its position by 76,848 shares, now holding 497,422 shares valued at approximately $15.9 million. Meanwhile, Vanguard Capital Management LLC added 461,702 shares, bringing its total to the same number, valued at $14.8 million. The Manufacturers Life Insurance Company decreased its holdings slightly by 4,157 shares, leaving it with 309,310 shares valued at about $9.9 million.

Analysts Set New Price Targets

Piper Sandler has maintained its 'buy' rating on OBT, setting a price target of $36 as of February 5, 2026. The firm has consistently reiterated its 'buy' rating over multiple periods, reflecting confidence in the stock's potential.

Bottom Line

Insider and institutional activities provide insights into OBT's current market perception. Gregory Holcombe's recent purchase, alongside other insider buys, indicates ongoing interest in the company. Institutional adjustments show varied strategies, with some funds reducing and others increasing their stakes. Piper Sandler's maintained 'buy' rating suggests continued optimism about OBT's prospects.